Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
The bill requires the HHS Secretary to establish, by January 1, 2026, a process allowing certain qualified clinical data registries and clinician-led clinical data registries to request and receive claims data (Medicare, and optionally Medicaid and CHIP) in a form determined appropriate by the Secretary. The purpose is to permit linkage of claims with clinical outcomes, perform provider quality assessments and improvement activities, conduct risk-adjusted analyses and research, and publish analyses including deidentified combined data.
Privacy and deidentification standards: liberals and centrists emphasize robust safeguards; conservatives worry federal access itself is risky.
Relative to its intended legislative type, this bill creates a specific new entitlement/authority (HHS must establish a process to allow qualified clinical data registries and clinician-led registries to request specified claims data for research and quality improvement), identifies eligible entities and purposes, and includes a cost-recovery mechanism.
The bill requires the HHS Secretary to establish, by January 1, 2026, a process allowing certain qualified clinical data registries and clinician-led clinical data registries to request and receive claims data (Medicare, and optionally Medicaid and CHIP) in a form determined appropriate by the Secretary.
The purpose is to permit linkage of claims with clinical outcomes, perform provider quality assessments and improvement activities, conduct risk-adjusted analyses and research, and publish analyses including deidentified combined data.
The bill specifies that those registries will not need to be designated as "qualified" or "quasi-qualified" entities under current law to access the data, allows provider-, specialty-, state-, or nationwide-level claims, and permits HHS to charge a fee equal to the cost of providing the data with proceeds deposited into the CMS Program Management Account.
On content alone the bill is a narrow, technocratic administrative change with limited fiscal impact and built-in constraints (cost-based fees, Secretary discretion, limited purposes). Those features tend to favor enactment. Remaining barriers are implementation complexity, possible privacy/state concerns, and the usual legislative process frictions.
Relative to its intended legislative type, this bill creates a specific new entitlement/authority (HHS must establish a process to allow qualified clinical data registries and clinician-led registries to request specified claims data for research and quality improvement), identifies eligible entities and purposes, and includes a cost-recovery mechanism. It leaves substantial operational, privacy, oversight, and procedural detail to agency rulemaking or administrative determinations.
Privacy and deidentification standards: liberals and centrists emphasize robust safeguards; conservatives worry federal access itself is risky.
These are examples from the analysis, not a ranked list of the most-affected groups.
Privacy and deidentification standards: liberals and centrists emphasize robust safeguards; conservatives worry federal access itself is risky.
This persona would generally view the bill positively as a practical step to expand access to data needed for clinical research, health equity analyses, and quality improvement.
They would appreciate removing certification barriers so clinician-led registries can link claims and outcomes and publish deidentified findings useful for patient safety and system reform.
However, they will watch for equitable access for smaller or community-focused registries and insist on robust privacy and anti-commercialization safeguards.
A centrist would generally view the bill as a pragmatic, technical measure to facilitate research and quality improvement, provided it includes appropriate privacy protections and reasonable cost controls.
They will value the potential for better evidence to guide policy and practice but will be attentive to administrative costs, oversight, and clarity about how data will be used.
They will favor measured safeguards to balance innovation, provider burden, and patient privacy.
A mainstream conservative would be cautious or skeptical about expanded federal access to health claims data.
While acknowledging potential benefits for quality improvement, they would be concerned about patient privacy, federal overreach, and unintended consequences for providers such as increased litigation or regulatory targeting.
They would generally support limited, clearly constrained data sharing with strong privacy protections and minimal new administrative burdens and costs.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone the bill is a narrow, technocratic administrative change with limited fiscal impact and built-in constraints (cost-based fees, Secretary discretion, limited purposes). Those features tend to favor enactment. Remaining barriers are implementation complexity, possible privacy/state concerns, and the usual legislative process frictions.
The bill has not accumulated any surfaced votes yet.
Privacy and deidentification standards: liberals and centrists emphasize robust safeguards; conservatives worry federal access itself is ri…
On content alone the bill is a narrow, technocratic administrative change with limited fiscal impact and built-in constraints (cost-based f…
Relative to its intended legislative type, this bill creates a specific new entitlement/authority (HHS must establish a process to allow qualified clinical data registries and clinician-led registries to request specifi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.